Mankind Pharma Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-20

Stock price
₹2565.80
Market cap
1,05,916 Cr
Stock P/E
55.5
P/B
6.40
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales2,579 Cr5,287 Cr7,894 Cr10,335 Cr2,893 Cr5,970 Cr3,230 Cr3,079 Cr3,570 Cr3,697 Cr3,567 Cr3,443 Cr
Operating expenses (approx.)1,865 Cr3,831 Cr5,761 Cr7,519 Cr2,111 Cr4,228 Cr2,323 Cr2,396 Cr2,644 Cr2,684 Cr2,682 Cr2,422 Cr
EBITDA713 Cr1,456 Cr2,133 Cr2,816 Cr782 Cr1,742 Cr907 Cr683 Cr927 Cr1,013 Cr886 Cr1,021 Cr
OPM %27.7%27.5%27.0%27.2%27.0%29.2%28.1%22.2%26.0%27.4%24.8%29.7%
Other income59 Cr119 Cr189 Cr281 Cr101 Cr210 Cr77 Cr251 Cr80 Cr92 Cr73 Cr114 Cr
Interest6 Cr15 Cr24 Cr34 Cr11 Cr18 Cr221 Cr191 Cr171 Cr170 Cr157 Cr142 Cr
Depreciation87 Cr184 Cr294 Cr398 Cr108 Cr213 Cr192 Cr231 Cr219 Cr222 Cr223 Cr223 Cr
Profit before tax620 Cr1,257 Cr1,815 Cr2,384 Cr664 Cr1,510 Cr494 Cr513 Cr537 Cr622 Cr506 Cr656 Cr
Tax %21.0%20.7%20.0%19.2%18.8%20.9%22.8%16.8%17.8%16.7%18.8%15.2%
Net profit494 Cr1,005 Cr1,465 Cr1,942 Cr543 Cr1,202 Cr385 Cr425 Cr445 Cr520 Cr414 Cr559 Cr
EPS (₹)₹12.15₹24.66₹35.99₹47.75₹13.39₹29.70₹9.45₹10.19₹10.62₹12.39₹9.90₹13.44

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8,749 Cr10,335 Cr12,207 Cr14,278 CrSign in for TTM
Operating expenses (approx.)6,849 Cr7,800 Cr8,653 Cr10,431 CrSign in for TTM
EBITDA1,901 Cr2,535 Cr3,555 Cr3,846 CrSign in for TTM
OPM %21.7%24.5%29.1%26.9%Sign in for TTM
Other income129 Cr281 Cr537 Cr359 CrSign in for TTM
Interest44 Cr34 Cr429 Cr639 CrSign in for TTM
Depreciation326 Cr398 Cr621 Cr886 CrSign in for TTM
Profit before tax1,659 Cr2,384 Cr2,504 Cr2,321 CrSign in for TTM
Tax %21.8%19.2%20.4%17.0%Sign in for TTM
Net profit1,310 Cr1,942 Cr2,011 Cr1,938 CrSign in for TTM
EPS (₹)₹32.00₹47.75₹49.28₹46.35Sign in for TTM
Dividend payout %0.0%0.0%0.0%2.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026
Equity capital40 Cr40 Cr41 Cr41 Cr
Reserves7,395 Cr9,323 Cr14,291 Cr16,259 Cr
Borrowings170 Cr207 Cr2,971 Cr3,419 Cr
Other liabilities1,922 Cr2,180 Cr10,220 Cr8,100 Cr
Total liabilities9,715 Cr11,963 Cr27,760 Cr28,080 Cr
Fixed assets (net)2,524 Cr2,932 Cr2,908 Cr2,960 Cr
CWIP493 Cr207 Cr306 Cr655 Cr
Investments1,346 Cr2,568 Cr1,851 Cr1,785 Cr
Other assets4,429 Cr6,650 Cr7,179 Cr7,144 Cr
Total assets9,715 Cr11,963 Cr27,760 Cr28,080 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity1,813 Cr2,152 Cr2,413 Cr3,121 Cr
Cash from investing-1,054 Cr-2,082 Cr-12,683 Cr-196 Cr
Cash from financing-740 Cr5 Cr10,290 Cr-2,953 Cr
Net cash flow19 Cr76 Cr21 Cr-28 Cr
Free cash flow (OCF − Capex)1,024 Cr1,837 Cr1,953 Cr2,495 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2023Mar 2024Mar 2025Mar 2026
ROCE %20.2%21.8%16.7%14.8%
ROE %16.8%20.0%13.6%11.6%
Debtor days2430——
Inventory days301306378341
Days payable202217——
Cash conversion cycle122119378341
Debt / equity0.020.020.200.21
Current ratio2.383.141.271.10
Net debt / EBITDA-0.07-0.070.720.79

Compare with peers

Loading peers…